Inovio Pharmaceuticals
INO
105 hedge funds and large institutions have $193M invested in Inovio Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 15 reducing their positions, and 9 closing their positions.
260% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 15
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
25% more capital invested
Capital invested by funds: $154M → $193M (+$39.1M)
7% more funds holding
Funds holding: 98 → 105 (+7)
0.67% more ownership
Funds ownership: 2.59% → 3.26% (+0.67%)
42% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $3.16M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.57M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$8.07M |
| 3 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$4.84M |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
+$3.52M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.26M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$2.04M |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$1.14M |
| 4 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
-$890K |
| 5 |
State Street
Boston,
Massachusetts
|
-$528K |
INO Hedge Fund Activity: Q2 2015 in Review
105 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q2 2015, worth a combined $193M — up 25% from $154M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new INO positions and 9 closed out — a net gain of 7 holders — while 54 added to existing stakes and 15 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $8.57M. The largest seller was Putnam Investments, cutting an estimated $5.26M.
- 105 institutional investors held Inovio Pharmaceuticals (INO) as of Q2 2015, up from 98 in Q1 2015.
- Funds reported $193M of Inovio Pharmaceuticals stock for Q2 2015, up 25% quarter-over-quarter.
- 16 funds opened new Inovio Pharmaceuticals positions in Q2 2015 and 9 closed out, a net change of +7 holders.
- The largest Inovio Pharmaceuticals buyer in Q2 2015 was Susquehanna International Group, an estimated $8.57M added.
- The largest Inovio Pharmaceuticals seller in Q2 2015 was Putnam Investments, an estimated $5.26M sold.
Based on aggregated 13F filings for Q2 2015.